EIGR

Eiger BioPharmaceuticals, Inc.
EIGR

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

EIGR was delisted on the 10th of April, 2024.

Back to rankings

30 hedge funds and large institutions have $51.1M invested in Eiger BioPharmaceuticals, Inc. in 2016 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more funds holding in top 10

Funds holding in top 10: →

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less funds holding

Funds holding: →

50% less first-time investments, than exits

New positions opened: 10 | Existing positions closed: 20

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $47K

Holders
30
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
$47K
Net Calls
Net Calls Change

Top Buyers

1
+$4.89M
2
+$4.35M
3
+$2.47M
4
PA
Perceptive Advisors
New York
+$1.76M
5
LOAMU
Lombard Odier Asset Management (USA)
New York
+$706K

Top Sellers

1
-$142K
2
-$125K
3
-$111K
4
Millennium Management
Millennium Management
New York
-$103K
5
Bank of New York Mellon
Bank of New York Mellon
New York
-$91K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$2K
27
$2K
28
$1K
29
$1K
30
$1K
31
–
32
–
33
–
34
–
35
–
36
–
37
–
38
–
39
–
40
–
41
–
42
–
43
–
44
–
45
–
46
–
47
–
48
–
49
–
1
2